Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

Patrick W Serruys; Sigmund Silber; Scot Garg; Robert Jan van Geuns; Gert Richardt; Pawel E Buszman; Henning Kelbaek; Adrianus Johannes van Boven; Sjoerd H Hofma; Axel Linke; Volker Klauss; William Wijns; Carlos Macaya; Philippe Garot; Carlo DiMario; Ganesh Manoharan; Ran Kornowski; Thomas Ischinger; Antonio Bartorelli; Jacintha Ronden; Marco Bressers; Pierre Gobbens; Manuela Negoita; Frank van Leeuwen; Stephan Windecker

doi:10.1056/NEJMoa1004130

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

Patrick W Serruys, Sigmund Silber, Scot Garg, Robert Jan van Geuns, Gert Richardt, Pawel E Buszman, Henning Kelbaek, Adrianus Johannes van Boven, Sjoerd H Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo DiMario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio Bartorelli, Jacintha RondenMarco Bressers, Pierre Gobbens, Manuela Negoita, Frank van Leeuwen, Stephan Windecker

612 Citationer (Scopus)

Abstract

New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration.

Originalsprog	Engelsk
Tidsskrift	New England Journal of Medicine
Vol/bind	363
Udgave nummer	2
Sider (fra-til)	136-46
Antal sider	11
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMoa1004130
Status	Udgivet - 8 jul. 2010

Adgang til dokumentet

10.1056/NEJMoa1004130

Citationsformater

Serruys, P. W., Silber, S., Garg, S., van Geuns, R. J., Richardt, G., Buszman, P. E., Kelbaek, H., van Boven, A. J., Hofma, S. H., Linke, A., Klauss, V., Wijns, W., Macaya, C., Garot, P., DiMario, C., Manoharan, G., Kornowski, R., Ischinger, T., Bartorelli, A., ... Windecker, S. (2010). Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. New England Journal of Medicine, 363(2), 136-46. https://doi.org/10.1056/NEJMoa1004130

Serruys, PW, Silber, S, Garg, S, van Geuns, RJ, Richardt, G, Buszman, PE, Kelbaek, H, van Boven, AJ, Hofma, SH, Linke, A, Klauss, V, Wijns, W, Macaya, C, Garot, P, DiMario, C, Manoharan, G, Kornowski, R, Ischinger, T, Bartorelli, A, Ronden, J, Bressers, M, Gobbens, P, Negoita, M, van Leeuwen, F & Windecker, S 2010, 'Comparison of zotarolimus-eluting and everolimus-eluting coronary stents', New England Journal of Medicine, bind 363, nr. 2, s. 136-46. https://doi.org/10.1056/NEJMoa1004130

@article{87285feea8d048d594f0ff3b20123657,

title = "Comparison of zotarolimus-eluting and everolimus-eluting coronary stents",

abstract = "New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration.",

author = "Serruys, {Patrick W} and Sigmund Silber and Scot Garg and {van Geuns}, {Robert Jan} and Gert Richardt and Buszman, {Pawel E} and Henning Kelbaek and {van Boven}, {Adrianus Johannes} and Hofma, {Sjoerd H} and Axel Linke and Volker Klauss and William Wijns and Carlos Macaya and Philippe Garot and Carlo DiMario and Ganesh Manoharan and Ran Kornowski and Thomas Ischinger and Antonio Bartorelli and Jacintha Ronden and Marco Bressers and Pierre Gobbens and Manuela Negoita and {van Leeuwen}, Frank and Stephan Windecker",

note = "2010 Massachusetts Medical Society",

year = "2010",

month = jul,

day = "8",

doi = "10.1056/NEJMoa1004130",

language = "English",

volume = "363",

pages = "136--46",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

TY - JOUR

T1 - Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

AU - Serruys, Patrick W

AU - Silber, Sigmund

AU - Garg, Scot

AU - van Geuns, Robert Jan

AU - Richardt, Gert

AU - Buszman, Pawel E

AU - Kelbaek, Henning

AU - van Boven, Adrianus Johannes

AU - Hofma, Sjoerd H

AU - Linke, Axel

AU - Klauss, Volker

AU - Wijns, William

AU - Macaya, Carlos

AU - Garot, Philippe

AU - DiMario, Carlo

AU - Manoharan, Ganesh

AU - Kornowski, Ran

AU - Ischinger, Thomas

AU - Bartorelli, Antonio

AU - Ronden, Jacintha

AU - Bressers, Marco

AU - Gobbens, Pierre

AU - Negoita, Manuela

AU - van Leeuwen, Frank

AU - Windecker, Stephan

N1 - 2010 Massachusetts Medical Society

PY - 2010/7/8

Y1 - 2010/7/8

N2 - New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration.

AB - New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration.

U2 - 10.1056/NEJMoa1004130

DO - 10.1056/NEJMoa1004130

M3 - Journal article

C2 - 20554978

SN - 0028-4793

VL - 363

SP - 136

EP - 146

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater